Literature DB >> 11803523

No association of the dopamine transporter gene 3' VNTR polymorphism with ADHD subtypes in a population sample of twins.

R D Todd1, Y J Jong, E A Lobos, W Reich, A C Heath, R J Neuman.   

Abstract

Dopamine pathway genes have been the subject of a variety of studies testing the association of candidate genes and liability for attention-deficit hyperactivity disorder (ADHD). Due to the known effects of stimulant medications such as methylphenidate on the dopamine transporter, a variety of case control and family-based transmission distortion genetic studies of ADHD have focused on DAT1 polymorphisms. The most widely reported positive finding has been with a variable number of tandem repeats (VNTR) polymorphism of unknown function in the 3' untranslated region of the DAT1 gene. In this report, we test for association of alleles of this polymorphism with ADHD using population-derived samples of twins. We use the transmission disequilibrium test and ADHD subtypes defined by both DSM-IV and latent class criteria. We fail to demonstrate any significant association or trend for association of any of the VNTR alleles with any of the variously defined ADHD subtypes. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11803523     DOI: 10.1002/ajmg.1611

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  14 in total

Review 1.  Intergenerational transmission of self-regulation: A multidisciplinary review and integrative conceptual framework.

Authors:  David J Bridgett; Nicole M Burt; Erin S Edwards; Kirby Deater-Deckard
Journal:  Psychol Bull       Date:  2015-05       Impact factor: 17.737

Review 2.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

Review 3.  Dopamine genes and attention-deficit hyperactivity disorder: a review.

Authors:  Salvatore DiMaio; Nathalie Grizenko; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

4.  Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder.

Authors:  Julia K Pinsonneault; Dawn D Han; Katherine E Burdick; Maria Kataki; Alessandro Bertolino; Anil K Malhotra; Howard H Gu; Wolfgang Sadee
Journal:  Neuropsychopharmacology       Date:  2011-04-27       Impact factor: 7.853

5.  Attention-Deficit Hyperactivity Disorder in the post-genomic era.

Authors:  Philip Asherson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

6.  ADHD risk alleles associated with opiate addiction: study of addicted parents and their children.

Authors:  Asher Ornoy; Victoria Finkel-Pekarsky; Einat Peles; Miriam Adelson; Shaul Schreiber; P Richard Ebstein
Journal:  Pediatr Res       Date:  2016-04-11       Impact factor: 3.756

Review 7.  Candidate gene studies of ADHD: a meta-analytic review.

Authors:  Ian R Gizer; Courtney Ficks; Irwin D Waldman
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

8.  Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1).

Authors:  Jonathan Mill; Philip Asherson; Ian Craig; Ursula M D'Souza
Journal:  BMC Genet       Date:  2005-01-31       Impact factor: 2.797

9.  Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction.

Authors:  D Sullivan; J K Pinsonneault; A C Papp; H Zhu; S Lemeshow; D C Mash; W Sadee
Journal:  Transl Psychiatry       Date:  2013-01-22       Impact factor: 6.222

10.  DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.

Authors:  Darko Turic; James Swanson; Edmund Sonuga-Barke
Journal:  Pharmgenomics Pers Med       Date:  2010-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.